Public Company News
Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure
Injectafer® (ferric carboxymaltose) is now the first and only intravenous (i.v.) iron replacement therapy in the U.S. indicated for improvement in exercise capacity in adult patients with symptomatic heart failure who have iron deficiency ST. GALLEN, Switzerland, June 5, 2023 /PRNewswire/ -- CSL...
2023-06-05 21:00
3905
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing
News Summary: * Integration of Sartorius' process scale multi-column chromatography with Waters' process analytical technology to provide robust analytical data for downstream biomanufacturing of mAbs, recombinant proteins, vaccines, and other biologics. * Integrated solution to deliver vita...
2023-06-05 20:00
4765
MITHAQ PROVIDES UPDATE TO FELLOW CONCERNED SHAREHOLDERS ON AIMIA'S FURTHER ATTEMPTS TO FRUSTRATE SHAREHOLDER DEMOCRACY AND AVOID TRANSPARENCY
* Calls on Aimia's entrenched board to provide access to proxies to prove board was legitimately elected; Mithaq has now been forced by the Company's intransigence to seek a court order to allow what should be an uncontroversial and commonplace review * Calls on Aimia's entrenched board to ce...
2023-06-05 19:30
3653
Prenetics Announces First Quarter 2023 Financial Results
HONG KONG, June 5, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial results for the first quarter endedMarch 31, 2023, along with recent business updates. First Quarter 2023 Fi...
2023-06-05 19:20
4525
Sirnaomics Reports Interim Results of STP705 Phase I Clinical Study for Medical Aesthetics Treatment in Adults Undergoing Abdominoplasty
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 5, 2023 /PRNewswire/ -- Sirnaomics Ltd.(the "Company", Stock Code: 2257.HK, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced the in...
2023-06-05 19:12
4512
EVE Energy Leadership Reveals World-Class Lithium Battery Innovations among the 2nd China International Battery Industry Cooperation Summit and CIBF 2023
* Mr. Samuel Sang, vice president of EVE Energy, delivered a keynote speech on the green and low-carbon manufacturing of lithium batteries and carbon reduction strategies at the 2nd China International Batter Industry Cooperation Summit * Dr. Zheng Zhong from the EVE Central Research Institut...
2023-06-05 16:00
4955
LG JOINS RE100 INITIATIVE, COMMITTING TO TRANSITION TO RENEWABLE ENERGY
Accelerating Journey Toward Carbon Neutrality, Company Continues Efforts to Realize ESG Vision of 'Better Life for All' SEOUL, South Korea, June 5, 2023 /PRNewswire/ -- LG Electronics (LG) has joined RE100 (Renewable Energy 100), a global initiative advocating for businesses to convert to 100 pe...
2023-06-05 16:00
3710
Rockwell Automation Features Executive Customers and Partners in New Thought Leadership Video Series
ROKStudios video program provides fresh perspectives on evolving technology trends and innovation driving better business outcomes in manufacturing, automation, and digital transformation BRUSSELS, June 5, 2023 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the world's largest company de...
2023-06-05 14:00
3201
Chubb Establishes Aviation Hub in Singapore
Expansion brings Chubb products and services closer to Asian customers
SINGAPORE, June 5, 2023 /PRNewswire/ -- Chubb today announced that it has set
up an aviation hub inSingapore to develop further its general aviation and
aerospace business.
2023-06-05 14:00
4614
Innovent Presents Phase 1b Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2023 ASCO Annual Meeting
ROCKVILLE, Md. and SUZHOU, China, June 5, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2023-06-05 08:00
6288
Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting
ROCKVILLE, Md. and SUZHOU, China, June 4, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2023-06-04 08:36
5525
Innovent Announces the Second Breakthrough Therapy Designation by NMPA for Olverembatinib for the Treatment of Patients with SDH-Deficient GIST
ROCKVILLE, Md. and SUZHOU, China, June 3, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...
2023-06-03 07:59
23880
Positive Shareholder Momentum Continues to Build In Support of Pelham Investment Partners LP's Campaign to Change Board of Directors of Nickel 28 Capital Corp., With Support From Shareholders and ISS
* Fellow shareholder Samara Capital Inc. holding voting control over approximately 7.4% of the issued and outstanding shares of Nickel 28 as of the record date, votesYELLOW Proxy "FOR" all Pelham's director nominees * ISS recognizes that "several credible governance and compensation issues ha...
2023-06-02 20:53
5087
Cboe Launches New Global Listing Offering for Companies and ETFs of the Purpose-Driven Innovation Economy
* Cboe leverages its existing network of stock exchanges in five markets around the world to facilitate access to capital and liquidity across the globe * Cboe Global Listings focuses on growth companies and asset managers committed to innovation with a global impact * Abaxx Technologies to ...
2023-06-02 20:00
6258
Transcenta Holding Limited (6628.HK) to Hold 2023 ASCO Business Update call Conference.
SUZHOU, China, June 2, 2023 /PRNewswire/ -- The management team of Transcenta Holding Limited (06628.HK) will attend the 2023 ASCO Business Update Call conference onJune 7, 2023. Transcenta is a clinical stage biopharmaceutical company with fully integrated capabilities in the discovery, research...
2023-06-02 19:14
6207
New market update: June 2023
GÖTEBORG, Sweden, June 2, 2023 /PRNewswire/ -- Concordia Maritime has published a new market update. The report is available atwww.concordiamaritime.com. In addition to commentary from CEOErik Lewenhaput, it also contains data and statistics regarding both tanker rates, ship values and the develo...
2023-06-02 17:23
3507
515 Fosun Family Day Sets Off Consumption Boom With Cumulative Sales of Nearly RMB10 Billion
HONG KONG, June 2, 2023 /PRNewswire/ -- Since the launch of Shanghai's 4th Double Five Shopping Festival, more than 1,000 promotion activities have been held successively in the month, setting off a consumption boom. As an essential part of the Double Five Shopping Festival, the 515 Fosun Family ...
2023-06-02 15:57
1837
Autoliv to launch its first motorcycle airbag in 2025
STOCKHOLM, June 2, 2023 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) (SSE: ALIVsdb) , is pioneering improved safety for 200 million road users through its holistic approach to motorcycle and scooter safety. The first new motorcycle safety product to reach the market will be the bag-on-bike airbag, wi...
2023-06-02 14:40
3799
2023 COMPUTEX：Fastest, Biggest, Best - It's all at GoDEX
TAIPEI, June 2, 2023 /PRNewswire/ -- 2023 Taipei International Computer Exhibition (COMPUTEX 2023) officially kicked off onMay 30th. As the world's second-largest andAsia's largest professional international computer exhibition, GoDEX, the fifth-largest label printer manufacturer in the world, s...
2023-06-02 11:27
1172
Innovent Enters into Clinical Trial Collaboration with Merck KGaA, Darmstadt, Germany Investigating Combination Therapy of IBI351 (KRASG12C Inhibitor) and Cetuximab (ERBITUX®)for KRASG12C-mutated NSCLC in China
ROCKVILLE, Md. and SUZHOU, China, June 2, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2023-06-02 08:00
7434
Week's Top Stories
Most Reposted
Ascentium Welcomes MGI Dobbyn Carafa, Strengthening Advisory Capability in Australia
[Picked up by 297 media titles]
2026-07-20 15:00
Singapore Tourism Board and Traveloka Renew Partnership to Welcome More Southeast Asian and Australian Travellers to Singapore
[Picked up by 291 media titles]
2026-07-17 18:18
A New Chapter Begins: Peach Blossoms Returns to Level 5 with the Debut of its Black Pearl One Diamond Tasting Journey
[Picked up by 290 media titles]
2026-07-23 16:00
MetaOptics to Deploy its Direct Laser Writer at the University of Arizona's Center of Semiconductor Manufacturing to Advance its U.S. Expansion
[Picked up by 287 media titles]
2026-07-22 07:30Omni HR Launches Native MCP Integration, Connecting AI Assistants to Live HR Data
[Picked up by 286 media titles]
2026-07-20 11:00
Most Read
Singapore Tourism Board and Traveloka Renew Partnership to Welcome More Southeast Asian and Australian Travellers to Singapore
2026-07-17 18:18
13066
Ascentium Welcomes MGI Dobbyn Carafa, Strengthening Advisory Capability in Australia
2026-07-20 15:00
10152